These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. 'Epitope fingerprinting' using overlapping 20-mer peptides of the MUC1 tandem repeat sequence. Schol DJ; Meulenbroek MF; Snijdewint FG; von Mensdorff-Pouilly S; Verstraeten RA; Murakami F; Kenemans P; Hilgers J Tumour Biol; 1998; 19 Suppl 1():35-45. PubMed ID: 9422087 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of Pepscan analyses for epitope mapping of anti-MUC1 monoclonal antibodies--a comparative study and review of five antibodies. Petrakou E; Murray A; Rosamund C; Graves L; Price MR Anticancer Res; 1998; 18(6A):4419-21. PubMed ID: 9891503 [TBL] [Abstract][Full Text] [Related]
7. Epitope mapping of antigenic MUC1 peptides to breast cancer antibody fragment B27.29: a heteronuclear NMR study. Grinstead JS; Schuman JT; Campbell AP Biochemistry; 2003 Dec; 42(48):14293-305. PubMed ID: 14640698 [TBL] [Abstract][Full Text] [Related]
8. Epitope mapping of PR81 anti-MUC1 monoclonal antibody following PEPSCAN and phage display techniques. Mohammadi M; Rasaee MJ; Rajabibazl M; Paknejad M; Zare M; Mohammadzadeh S Hybridoma (Larchmt); 2007 Aug; 26(4):223-30. PubMed ID: 17725384 [TBL] [Abstract][Full Text] [Related]
9. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1. Ryuko K; Schol DJ; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Karuntu-Wanamarta YA; Verstraeten RA; Miyazaki K; Kenemans P; Hilgers J Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613 [TBL] [Abstract][Full Text] [Related]
10. Effect of desialylation on binding, affinity, and specificity of 56 monoclonal antibodies against MUC1 mucin. Dai J; Allard WJ; Davis G; Yeung KK Tumour Biol; 1998; 19 Suppl 1():100-10. PubMed ID: 9422094 [TBL] [Abstract][Full Text] [Related]
11. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma. Henderikx P; Kandilogiannaki M; Petrarca C; von Mensdorff-Pouilly S; Hilgers JH; Krambovitis E; Arends JW; Hoogenboom HR Cancer Res; 1998 Oct; 58(19):4324-32. PubMed ID: 9766660 [TBL] [Abstract][Full Text] [Related]
12. Effect of glycosylation of a synthetic MUC1 mucin-core-related peptide on recognition by anti-mucin antibodies. Spencer DI; Price MR; Tendler SJ; De Matteis CI; Stadie T; Hanisch FG Cancer Lett; 1996 Feb; 100(1-2):11-5. PubMed ID: 8620429 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and antibody recognition of synthetic antigens from MUC1. Bánóczi Z; Mezõ G; Windberg E; Uray K; Majer Z; Hudecz F J Pept Sci; 2008 May; 14(5):610-6. PubMed ID: 17975847 [TBL] [Abstract][Full Text] [Related]
14. Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat. Tarp MA; Sørensen AL; Mandel U; Paulsen H; Burchell J; Taylor-Papadimitriou J; Clausen H Glycobiology; 2007 Feb; 17(2):197-209. PubMed ID: 17050588 [TBL] [Abstract][Full Text] [Related]
15. Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides. von Mensdorff-Pouilly S; Petrakou E; Kenemans P; van Uffelen K; Verstraeten AA; Snijdewint FG; van Kamp GJ; Schol DJ; Reis CA; Price MR; Livingston PO; Hilgers J Int J Cancer; 2000 Jun; 86(5):702-12. PubMed ID: 10797294 [TBL] [Abstract][Full Text] [Related]
17. Structural and dynamic consequences of increasing repeats in a MUC1 peptide tumor antigen. Schuman JT; Grinstead JS; Apostolopoulos V; Campbell AP Biopolymers; 2005 Feb; 77(2):107-20. PubMed ID: 15635690 [TBL] [Abstract][Full Text] [Related]
18. Characterization of an anti-MUC1 monoclonal antibody with potential as a cancer vaccine. Qi W; Schultes BC; Liu D; Kuzma M; Decker W; Madiyalakan R Hybrid Hybridomics; 2001; 20(5-6):313-24. PubMed ID: 11839249 [TBL] [Abstract][Full Text] [Related]
19. Characterization of a panel of monoclonal antibodies using GalNAc glycosylated peptides and recombinant MUC1. Reis CA; Hassan H; Bennett EP; Clausen H Tumour Biol; 1998; 19 Suppl 1():127-33. PubMed ID: 9422098 [TBL] [Abstract][Full Text] [Related]
20. Mouse mucin 1 (MUC1) defined by monoclonal antibodies. Xing PX; Lees C; Lodding J; Prenzoska J; Poulos G; Sandrin M; Gendler S; McKenzie IF Int J Cancer; 1998 Jun; 76(6):875-83. PubMed ID: 9626356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]